Urologic Oncology: Seminars and Original Investigations
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.8 | Q2 | 64.9% | 0.997 | Q1 | 83.8% |
| 2024 | 2.3 | Q2 | 60.4% | 0.855 | Q1 | 79.9% |
| 2023 | 2.4 | Q2 | 64.3% | 0.867 | Q1 | 82.0% |
| 2022 | 2.7 | Q2 | 65.6% | 0.874 | Q1 | 83.0% |
| 2021 | 3.0 | Q3 | 62.2% | 0.818 | Q1 | 81.8% |
| 2020 | — | — | 1.150 | Q1 | 88.1% | |
| 2019 | — | — | 1.059 | Q1 | 86.9% | |
| 2018 | — | — | 1.199 | Q1 | 87.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-2496
ISSN
1078-1439
country
UScoverage
1995-2026